|
|
|
|
| LEADER |
02880nam a22003853i 4500 |
| 001 |
EBC6422746 |
| 003 |
MiAaPQ |
| 005 |
20231204023215.0 |
| 006 |
m o d | |
| 007 |
cr cnu|||||||| |
| 008 |
231204s2015 xx o ||||0 eng d |
| 020 |
|
|
|a 9783319254609
|q (electronic bk.)
|
| 020 |
|
|
|z 9783319254586
|
| 035 |
|
|
|a (MiAaPQ)EBC6422746
|
| 035 |
|
|
|a (Au-PeEL)EBL6422746
|
| 035 |
|
|
|a (OCoLC)1066198411
|
| 040 |
|
|
|a MiAaPQ
|b eng
|e rda
|e pn
|c MiAaPQ
|d MiAaPQ
|
| 050 |
|
4 |
|a R1
|
| 100 |
1 |
|
|a Shantsila, Eduard.
|
| 245 |
1 |
0 |
|a Non-Vitamin K Antagonist Oral Anticoagulants :
|b A Concise Guide.
|
| 250 |
|
|
|a 1st ed.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing AG,
|c 2015.
|
| 264 |
|
4 |
|c ©2016.
|
| 300 |
|
|
|a 1 online resource (82 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Intro -- Contents -- Chapter 1: Introduction -- 1.1 Overview of the Coagulation Cascade -- 1.2 Current Approaches to Anticoagulation -- 1.3 The Ideal Anticoagulant -- References -- Chapter 2: Direct Thrombin Inhibitors -- 2.1 Historical Excursus: Ximelagatran -- 2.2 Dabigatran Etexilate -- 2.2.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 2.2.2 Venous Thromboembolism Treatment -- 2.2.3 Stroke Prevention in Atrial Fibrillation -- 2.2.4 Other Directions -- References -- Chapter 3: Factor Xa Inhibitors -- 3.1 Rivaroxaban -- 3.1.1 Venous Thromboembolism Prevention following Joint Surgery -- 3.1.2 Treatment of Venous Thromboembolism -- 3.1.3 Stroke Prevention in Atrial Fibrillation -- 3.1.4 Acute Coronary Syndromes -- 3.2 Apixaban -- 3.2.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 3.2.2 Stroke Prevention in Atrial Fibrillation -- 3.2.3 Thromboprophylaxis in Other Clinical Settings -- 3.2.4 Treatment of Venous Thrombosis -- 3.2.5 Acute Coronary Syndrome -- 3.3 Edoxaban -- 3.3.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 3.3.2 Stroke Prevention in Atrial Fibrillation -- 3.3.3 Treatment of Venous Thromboembolism -- 3.4 Emerging Factor Xa Inhibitors -- 3.4.1 Betrixaban -- 3.4.2 TTP889 -- References -- Chapter 4: Conclusions -- 4.1 Future Directions -- References.
|
| 588 |
|
|
|a Description based on publisher supplied metadata and other sources.
|
| 590 |
|
|
|a Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2023. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a LIP, Gregory.
|
| 776 |
0 |
8 |
|i Print version:
|a Shantsila, Eduard
|t Non-Vitamin K Antagonist Oral Anticoagulants
|d Cham : Springer International Publishing AG,c2015
|z 9783319254586
|
| 797 |
2 |
|
|a ProQuest (Firm)
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/matrademy/detail.action?docID=6422746
|z Click to View
|
